PRICE T ROWE ASSOCIATES INC /MD/ - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 276 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q4 2023. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2024$23,357
-9.0%
583,906
-0.1%
0.00%0.0%
Q1 2024$25,668
-29.3%
584,544
-0.4%
0.00%
-40.0%
Q4 2023$36,304
+38.6%
586,957
+3.0%
0.01%
+25.0%
Q3 2023$26,202
-10.0%
569,712
+12.5%
0.00%0.0%
Q2 2023$29,098
+65.6%
506,308
+8.1%
0.00%
+33.3%
Q1 2023$17,567
-20.6%
468,420
-40.6%
0.00%
-25.0%
Q4 2022$22,112
-99.9%
789,170
-2.4%
0.00%0.0%
Q3 2022$22,727,000
+301.3%
808,731
+396.7%
0.00%
+300.0%
Q2 2022$5,664,000162,8140.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q4 2023
NameSharesValueWeighting ↓
MQS Management LLC 10,935$255,0000.41%
GLOBEFLEX CAPITAL L P 144,692$3,370,0000.34%
CORNERCAP INVESTMENT COUNSEL INC 58,975$1,374,0000.20%
Factorial Partners, LLC 10,900$254,0000.17%
FEDERATED HERMES, INC. 3,464,335$80,684,0000.15%
Campbell & CO Investment Adviser LLC 14,800$345,0000.12%
FULLER & THALER ASSET MANAGEMENT, INC. 611,462$14,241,0000.08%
Summit Global Investments 45,900$1,069,0000.07%
RENAISSANCE GROUP LLC 63,559$1,480,0000.06%
PDT Partners, LLC 33,459$779,0000.06%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders